Skip to content

A Randomized Controlled Study of Moxibustion in the Treatment of Shoulder-Hand Syndrome after Ischemic Stroke

A Randomized Controlled Study of Moxibustion in the Treatment of Shoulder-Hand Syndrome after Ischemic Stroke

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2100005261
Enrollment
Unknown
Registered
2021-09-01
Start date
2021-10-01
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

post-stroke shoulder-hand syndrome

Interventions

Sponsors

The First Affiliated Hospital of He'nan University of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Patients who meet the diagnostic criteria for stroke (including ischemic and hemorrhagic stroke) by computed tomography (CT) or magnetic resonance imaging (MRI); 2. Aged 18 to 75 years, the course of the disease does not exceed 12 months; 3. All vital signs after stroke are stable, meet the diagnostic criteria for shoulder-hand syndrome, and belong to stage I or II according to the staging criteria; 4. Those who have a clear consciousness and can perform and tolerate "fine moxibustion" treatment.

Exclusion criteria

Exclusion criteria: 1. Patients with other serious diseases that may affect the results of treatment and threaten life, such as heart disease, liver disease, lung disease, kidney disease, diabetes, osteoporosis or bleeding tendency; 2. Patients who are pregnant, breastfeeding or planning to become pregnant; 3. Patients with severe cognitive impairment who cannot cooperate with treatment.

Design outcomes

Primary

MeasureTime frame
The Fugl–Meyer Assessment for upper Extremity;Assessment of hand swelling;visual analogue scale ;

Secondary

MeasureTime frame
Surface Electromyography ;range of motion;Te Modified Barthel Index Score;

Countries

China

Contacts

Public ContactWang Xiaodan

He'nan University of Chinese Medicine

18639021065@163.com+86 18639021065

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026